Trinational
HealthTech Days 2
Day 1 Wed, Oct 13
EU market access strategy for health products and country particularities
14:00 - 14:15
Opening remarks
Digital health/Medtech session 14:15 - 15:00
How to access clinics as a startup?
From the 1st experimentations until the clinical trials.
This session will shed some light on how startup teams can get access to hospitals. To this end the speakers will present different approaches and strategies ranging from consultancy services to whole clinical departments including patient, nurses and doctors interacting with teams.
Biotech session 14:15 - 15:00
When and how to start discussing with major corporates / big pharma as Start up?
This session will, in a very open manner, address topics relevant for
start-ups wanting to collaborate with corporates / big pharma. What do you need to consider to maximize your chances for collaboration and when is the best time in your journey to think about this endeavor, are just a few of the questions that will be addressed during this session.
15:25 - 16:25
Successful access and cooperation
How does the successful acquisition of a significant investment work, what are the main hurdles after the first access in clinics and how can corporates and startups work together to accelerate this journey?
16:25 - 16:40
Closing remarks
Day 2 Thu, Oct 14
One-on-One meetings of startups and investors/corporates
Speakers
Thomas Scheuerle
Managing Director at BadenCampus
Guillaume Vetter-Genoud
Head of deeptech/healthcare, SEMIA
Bodo Brückner
Startup Advisor; Coordinator Lifescience Accelerator Baden-Wuerttemberg
Maarten van Winckel
Startup Community & Initiatives at University of Basel
Markus Bühler
Coordinator Lifescience Accelerator Baden- Wuerttemberg
Digital health/Medtech session
Speakers
Annegret Genger
Senior Consultant Regulatory and Clinical Affairs at Seleon
Mirjam Schleske
Organisational Management INSPIRE Living Lab
Christian Haverkamp
Acting Director, “Institut für Digitalisierung in der Medizin” at Uniklinik Freiburg
Matis Ringdal
CEO at Pixacare
Olivier Terenzi
Clinical research project manager at OMEOS
Biotech session
Speakers
Samantha Brandler
Head of Research Innovation, Europe at CSL Behring
Michael R Huebner
Director Early Innovation Partnering at Johnson and Johnson
Ashley Nagle
Vice President of Business Development at RemedyBio
Jonathan Butcher
Head of Business Development and Alliance Management at BioVersys
Speakers
Christian Kraft
Director Corporate Development – External Innovation at B. Braun Innovation Hub & Managing Director CeCaVa GmbH & Co. KG
Michael Luettgen
Liason Manager at German EIT Health GmbH Dipl.-Ing. Catherine Schreiber, deputy CEO & COO at ADVITOS GmbH
Corporates
Venture capital
Business angels
KIC
